Compare · BSX vs SKIN
BSX vs SKIN
Side-by-side comparison of Boston Scientific Corporation (BSX) and SkinHealth Systems Inc. (SKIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BSX and SKIN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BSX is the larger of the two at $72.77B, about 886.1x SKIN ($82.1M).
- Over the past year, BSX is down 51.1% and SKIN is down 60.5% - BSX leads by 9.4 points.
- BSX has been more active in the news (12 items in the past 4 weeks vs 2 for SKIN).
- Both have 25 recent analyst ratings on file.
- Company
- Boston Scientific Corporation
- SkinHealth Systems Inc.
- Price
- $48.95+0.48%
- $0.63-1.10%
- Market cap
- $72.77B
- $82.1M
- 1M return
- -9.19%
- +7.80%
- 1Y return
- -51.07%
- -60.50%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 12
- 2
- Recent ratings
- 25
- 25
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
SkinHealth Systems Inc.
Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems. The company also provides HydraFacial CONNECT platform, a three-level industry certification program that will advance aesthetic professionals' skills and give them recognition, respect, and rewards; and system surgical smoke evacuators that vacuums the plume created by laser and electrocautery treatments, such as hair removal, tattoo removal, erbium, and veterinary procedures. Its system surgical smoke evacuators are used by hospitals, plastic surgeons, cosmetic surgeons, OB/GYN, veterinarians, and others. In addition, it offers marketing support services. Its products are distributed worldwide through its sales network. The company was founded in 1997 and is based in Signal Hill, California with a location in Long Beach, California.
Latest BSX
- Chairman, President & CEO Mahoney Michael F gifted 386,755 shares (SEC Form 4)
- Boston Scientific downgraded by Wolfe Research
- Boston Scientific downgraded by Wells Fargo with a new price target
- Director Ludwig Edward J bought $202,914 worth of shares (3,580 units at $56.68), increasing direct ownership by 16% to 25,359 units (SEC Form 4)
- Director Pegus Cheryl bought $99,987 worth of shares (1,770 units at $56.49) (SEC Form 4)
- Director Habiger David C bought $251,098 worth of shares (4,450 units at $56.43), increasing direct ownership by 47% to 13,878 units (SEC Form 4)
- SEC Form SD filed by Boston Scientific Corporation
- FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints
- Boston Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Boston Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest SKIN
- Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
- Amendment: SkinHealth Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SkinHealth Systems Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 10-Q filed by SkinHealth Systems Inc.
- SkinHealth Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SkinHealth Systems Reports First Quarter 2026 Financial Results
- SkinHealth Systems Inc. filed SEC Form 8-K: Leadership Update
- Amendment: SEC Form SCHEDULE 13G/A filed by SkinHealth Systems Inc.
- SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026
- SEC Form DEF 14A filed by SkinHealth Systems Inc.